Development of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
The treatment of cancer has long been a challenging endeavor due to the complexity and heterogeneity of the disease. Conventional chemotherapy often lacks specificity, leading to severe side effects and limited efficacy. To address these limitations, the development of novel drug delivery systems for targeted cancer therapy has emerged as a promising approach. This thesis focuses on the design, optimization, and evaluation of advanced drug delivery systems that can selectively target cancer cells while minimizing off-target effects. Chapter 1 provides an introduction to the research topic, discussing the background of the study, the problem statement, objectives, limitations, scope, significance, and the structure of the thesis. The definitions of key terms relevant to the study are also presented. Chapter 2 presents a comprehensive literature review encompassing ten key areas related to drug delivery systems for targeted cancer therapy. The review covers recent advancements in nanoparticle-based drug delivery, liposomal formulations, polymer-drug conjugates, antibody-drug conjugates, and other innovative approaches for improving drug specificity and efficacy in cancer treatment. Chapter 3 outlines the research methodology employed in this study, including the design and synthesis of novel drug delivery systems, in vitro and in vivo evaluation techniques, and data analysis methods. The chapter also discusses the selection criteria for cancer cell lines, animal models, and relevant assays for assessing the efficacy and safety of the developed drug delivery systems. Chapter 4 presents a detailed discussion of the findings obtained from the experimental studies. This includes the characterization of the developed drug delivery systems, their ability to target cancer cells, drug release profiles, cytotoxicity studies, and in vivo pharmacokinetics and biodistribution analyses. The chapter also highlights any challenges encountered during the research and potential avenues for future investigations. Chapter 5 serves as the conclusion and summary of the thesis, providing a synthesis of the key findings, implications of the research outcomes, and recommendations for further research in the field of targeted cancer therapy using novel drug delivery systems. The chapter concludes by emphasizing the potential of these advanced drug delivery platforms to revolutionize cancer treatment by enhancing therapeutic efficacy and reducing adverse effects. In conclusion, the development of novel drug delivery systems for targeted cancer therapy holds great promise for improving the outcomes of cancer patients. This thesis contributes to the growing body of knowledge in this field by presenting innovative approaches to enhance drug delivery specificity and efficacy. The findings of this research have the potential to impact the future of cancer treatment by providing safer and more effective therapeutic options for patients.